Viewing Study NCT02285959


Ignite Creation Date: 2025-12-24 @ 2:52 PM
Ignite Modification Date: 2026-02-24 @ 3:14 PM
Study NCT ID: NCT02285959
Status: UNKNOWN
Last Update Posted: 2022-08-10
First Post: 2014-11-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme
Sponsor: Global Neurosciences Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module